Supplementary Table 4 from Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Antitumor Immunity
Year: 2025
Type: supplementary-materials
Abstract: Clinical characteristics for the NSCLC cohort analyzed sex difference of survival in patients treated with anti-PD-1 antibody
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4416681447